Belay Diagnostics

Belay Diagnostics

Biotechnology Research

Chicago, Illinois 1,369 followers

About us

Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.

Website
belaydiagnostics.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Chicago, Illinois
Type
Privately Held
Founded
2022

Locations

Employees at Belay Diagnostics

Updates

Similar pages